Mrv0541 02231218112D 19 21 0 0 1 0 999 V2000 5.2224 -1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 1.4438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.2063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -1.4438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -1.4438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6515 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9370 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6515 2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 4 1 0 0 0 0 1 13 1 0 0 0 0 2 6 1 0 0 0 0 2 7 1 0 0 0 0 2 11 1 0 0 0 0 3 12 1 0 0 0 0 3 14 2 0 0 0 0 4 14 1 0 0 0 0 5 17 1 0 0 0 0 5 19 2 0 0 0 0 6 8 1 0 0 0 0 7 9 1 0 0 0 0 8 10 1 0 0 0 0 9 10 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 15 17 2 0 0 0 0 16 18 2 0 0 0 0 18 19 1 0 0 0 0 M END > DB05444 > drugbank > C(C1CONC(=N1)C1=CN=CC=C1)N1CCCCC1 > InChI=1S/C14H20N4O/c1-2-7-18(8-3-1)10-13-11-19-17-14(16-13)12-5-4-6-15-9-12/h4-6,9,13H,1-3,7-8,10-11H2,(H,16,17) > QWVRTSZDKPRPDF-UHFFFAOYSA-N > C14H20N4O > 260.3348 > 260.163711282 > 5 > 39 > 0.9808434555456118 > 28.59987243147498 > 1 > 1 > 0 > 1 > 5-[(piperidin-1-yl)methyl]-3-(pyridin-3-yl)-5,6-dihydro-2H-1,2,4-oxadiazine > 1.31 > 1.0965830383333333 > -2.46 > 0 > 1 > 3 > 1 > 18.804624328876216 > 8.683209283621757 > 49.75 > 84.6574 > 3 > 1 > 9.08e-01 g/l > tetrahydrofolic acid > 0 > DB05444 > investigational > Iroxanadine > Iroxanadine $$$$